0000899243-18-006041.txt : 20180302 0000899243-18-006041.hdr.sgml : 20180302 20180302141403 ACCESSION NUMBER: 0000899243-18-006041 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180301 FILED AS OF DATE: 20180302 DATE AS OF CHANGE: 20180302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sprague John M CENTRAL INDEX KEY: 0001730056 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 18661180 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-01 0 0001492674 T2 Biosystems, Inc. TTOO 0001730056 Sprague John M 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 5.08 2018-03-01 4 A 0 225000 0.00 A 2028-03-01 Common Stock 225000 225000 D 25% of the total shares vest on 01/30/2019, and the remaining shares vest in substantially equal monthly installments over the following 36 months, to be fully vested on 01/30/2022. /s/ Michael Gibbs, Attorney-in-fact 2018-03-02